Leptin gene therapy improves type1 and type2 diabetes and diet-induced obesity in animal models, such as ob/ob, diet-induced obese mice, insulin-deficient type 1 diabetes mice, and insulin-dependent diabetes animals. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.